Linda Johnson

Read the latest stories and analysis from Linda Johnson.

Viagra ads target women for 1st time

Viagra ads target women for 1st time

Linda Johnson · September 30, 2014 3:37 pm

FDA OKs Merck drug, 1st in new cancer drug class

FDA OKs Merck drug, 1st in new cancer drug class

Linda Johnson · September 4, 2014 9:41 pm

Allergan reviews meeting requests in takeover bid

Allergan reviews meeting requests in takeover bid

Linda Johnson · August 23, 2014 6:29 pm

Allergan sues Valeant, claims fraud in buy attempt

Allergan sues Valeant, claims fraud in buy attempt

Linda Johnson · August 1, 2014 9:32 pm

Biotech drugmaker Amgen laying off at least 2,400

Biotech drugmaker Amgen laying off at least 2,400

Linda Johnson · July 29, 2014 11:17 pm

Pfizer’s 2Q profit sinks 79 pct but tops forecasts

Pfizer’s 2Q profit sinks 79 pct but tops forecasts

Linda Johnson · July 29, 2014 5:37 pm

Merck 2Q profit more than doubles

Merck 2Q profit more than doubles

Linda Johnson · July 29, 2014 3:44 pm

J&J 2Q profit climbs 13 percent on new-drug sales

J&J 2Q profit climbs 13 percent on new-drug sales

Linda Johnson · July 15, 2014 4:27 pm

Merck to pay $3.85B for hepatitis C drug developer

Merck to pay $3.85B for hepatitis C drug developer

Linda Johnson · June 9, 2014 7:31 pm

New allergy tablets offer alternative to shots

New allergy tablets offer alternative to shots

Linda Johnson · June 2, 2014 10:54 am

Nonprescription Nexium heartburn medicine launches

Nonprescription Nexium heartburn medicine launches

Linda Johnson · May 27, 2014 6:28 pm

Pfizer ups offer for AstraZeneca again, to $119B

Pfizer ups offer for AstraZeneca again, to $119B

Linda Johnson · May 19, 2014 4:06 am